Osteoarthritis
Welcome,         Profile    Billing    Logout  
 99 Companies   114 Products   114 Products   61 Mechanisms of Action   11 Trials   1875 News 


12345678910111213...3637»
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date, Trial primary completion date:  Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study (clinicaltrials.gov) -  May 1, 2019   
    P=N/A,  N=31, Completed, 
    Phase classification: P4 --> P=N/A Active, not recruiting --> Completed | Trial completion date: Sep 2017 --> Jul 2018 | Trial primary completion date: Sep 2017 --> Jul 2018
  • ||||||||||  Trial completion:  Femoral Remodeling Following Total Hip Arthroplasty With OMNI Apex Modular (clinicaltrials.gov) -  Apr 26, 2019   
    P=N/A,  N=73, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Sep 2017 --> Jul 2018 | Trial primary completion date: Sep 2017 --> Jul 2018 Active, not recruiting --> Completed
  • ||||||||||  Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty (clinicaltrials.gov) -  Apr 20, 2019   
    P=N/A,  N=67, Terminated, 
    Active, not recruiting --> Completed N=120 --> 67 | Trial completion date: Dec 2024 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2023 --> Dec 2018; Business decision was made to remove the CE mark from this product, thus prompting the closing of this study.
  • ||||||||||  Trial completion, Trial completion date:  10003 PRO Current Products (clinicaltrials.gov) -  Apr 20, 2019   
    P=N/A,  N=842, Completed, 
    N=120 --> 67 | Trial completion date: Dec 2024 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2023 --> Dec 2018; Business decision was made to remove the CE mark from this product, thus prompting the closing of this study. Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Aug 2018
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial primary completion date:  Vitamin D and the Free Hormone Hypothesis (clinicaltrials.gov) -  Mar 26, 2019   
    P=N/A,  N=20, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Feb 2015 --> Feb 2017
  • ||||||||||  eszopiclone / Generic mfg.
    Enrollment change:  Insomnia and Osteoarthritis Study (clinicaltrials.gov) -  Mar 14, 2019   
    P=N/A,  N=30, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Feb 2015 --> Feb 2017 N=105 --> 30
  • ||||||||||  Trial completion:  Joint Injections for Osteoarthritic Knee Pain (clinicaltrials.gov) -  Feb 16, 2019   
    P1/2,  N=98, Completed, 
    Phase classification: P2/3 --> P=N/A Active, not recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  DePuy Attune Total Knee Arthroplasty RSA Study (clinicaltrials.gov) -  Feb 1, 2019   
    P=N/A,  N=30, Completed, 
    Recruiting --> Completed | Trial completion date: Feb 2018 --> Feb 2019 | Trial primary completion date: Dec 2017 --> Feb 2019 Active, not recruiting --> Completed
  • ||||||||||  Enrollment change, Trial withdrawal:  Gender Solutions Natural Knee Post-Market Study (clinicaltrials.gov) -  Jan 9, 2019   
    P=N/A,  N=0, Withdrawn, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Aug 2018 | Trial primary completion date: Dec 2018 --> Aug 2018 N=300 --> 0 | Suspended --> Withdrawn
  • ||||||||||  Trial completion, Phase classification, Enrollment change:  Total Knee Arthroplasty (TKA) Cemented Versus Cementless Tibial Prosthesis Study (clinicaltrials.gov) -  Jan 8, 2019   
    P=N/A,  N=106, Completed, 
    N=300 --> 0 | Suspended --> Withdrawn Active, not recruiting --> Completed | Phase classification: P2/3 --> PN/A | N=250 --> 106
  • ||||||||||  Euflexxa (hyaluronic acid) / Ferring
    Phase classification:  Post-op Treatment With Hyaluronic Acid Injections (clinicaltrials.gov) -  Jan 8, 2019   
    P=N/A,  N=34, Terminated, 
    Active, not recruiting --> Completed | Phase classification: P2/3 --> PN/A | N=250 --> 106 Phase classification: P4 --> P=N/A
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date:  Use of FlexHD as Post Trapeziectomy Spacer (clinicaltrials.gov) -  Jan 7, 2019   
    P4,  N=30, Completed, 
    Phase classification: P4 --> P=N/A Active, not recruiting --> Completed | Trial completion date: Mar 2017 --> Dec 2017
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Regenexx (clinicaltrials.gov) -  Jan 4, 2019   
    P=N/A,  N=48, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Mar 2017 --> Dec 2017 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Phase classification, Enrollment change:  Augment (clinicaltrials.gov) -  Dec 5, 2018   
    P=N/A,  N=299, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | N=201 --> 299
  • ||||||||||  Trial completion:  Clinical Outcomes With Omni Apex Ultracongruent Knee System (clinicaltrials.gov) -  Dec 5, 2018   
    P=N/A,  N=69, Completed, 
    Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | N=201 --> 299 Active, not recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date, Trial primary completion date:  Supine Sleeping After Total Hip Replacement (clinicaltrials.gov) -  Nov 27, 2018   
    P=N/A,  N=456, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Mar 2020 --> Mar 2018 | Trial primary completion date: Mar 2019 --> Mar 2018
  • ||||||||||  Enrollment change, Trial withdrawal:  PEPOA-E: Patient Education Program for Osteoarthritis With Exercise Included (clinicaltrials.gov) -  Nov 21, 2018   
    P=N/A,  N=0, Withdrawn, 
    Active, not recruiting --> Completed | Trial completion date: Mar 2020 --> Mar 2018 | Trial primary completion date: Mar 2019 --> Mar 2018 N=100 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  PAS:IDE: Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects (clinicaltrials.gov) -  Nov 19, 2018   
    P=N/A,  N=350, Completed, 
    N=350 --> 231 Active, not recruiting --> Completed | Trial completion date: Mar 2018 --> Aug 2017 | Trial primary completion date: Mar 2018 --> Jun 2017
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Facet Wedge Post Market Study (clinicaltrials.gov) -  Oct 19, 2018   
    P=N/A,  N=50, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Phase classification:  Progressive Rehabilitation Following Total Knee Arthroplasty (clinicaltrials.gov) -  Oct 11, 2018   
    P=N/A,  N=185, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P1 --> PN/A
  • ||||||||||  Trial completion date, Trial termination, Trial primary completion date:  Clinical Outcomes of Knee Replacement (clinicaltrials.gov) -  Sep 26, 2018   
    P=N/A,  N=316, Terminated, 
    Active, not recruiting --> Completed | Phase classification: P1 --> PN/A Trial completion date: Feb 2028 --> Sep 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2026 --> Sep 2018; Changes in funding.
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date, Trial primary completion date, Adverse events:  Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions (clinicaltrials.gov) -  Sep 25, 2018   
    P=N/A,  N=3000, Completed, 
    Trial completion date: Feb 2028 --> Sep 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2026 --> Sep 2018; Changes in funding. Recruiting --> Completed | Trial completion date: Mar 2018 --> Jan 2017 | Trial primary completion date: Mar 2018 --> Dec 2016
  • ||||||||||  Trial completion, Trial completion date, HEOR, Surgery, Cost effectiveness:  Comparison of Ways to Prepare Patients for Decisions About Joint Replacement Surgery (clinicaltrials.gov) -  Sep 10, 2018   
    P=N/A,  N=343, Completed, 
    Phase classification: P3 --> P=N/A | N=30 --> 20 Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> May 2017
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date, Surgery:  Occupational Therapy and Surgery in Carpometacarpal Osteoarthritis (clinicaltrials.gov) -  Aug 31, 2018   
    P=N/A,  N=180, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> May 2017 Active, not recruiting --> Completed | Trial completion date: Dec 2019 --> Aug 2018
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Efficacy and Safety of NEM (clinicaltrials.gov) -  Aug 22, 2018   
    P=N/A,  N=166, Completed, 
    Trial completion date: Jul 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Dec 2018 Recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Comparison of Two Resurfacing Prostheses in the Treatment of Osteoarthritis of the Shoulder (clinicaltrials.gov) -  Aug 16, 2018   
    P=N/A,  N=32, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed | N=60 --> 32 | Trial completion date: Jan 2017 --> Jan 2018 | Trial primary completion date: Jan 2017 --> Mar 2016
  • ||||||||||  Enrollment change, Trial withdrawal:  Follow up Study of Patients Undergoing Total Hip Arthroplasty CERAFIT (clinicaltrials.gov) -  Aug 14, 2018   
    P1/2,  N=0, Withdrawn, 
    Active, not recruiting --> Completed | N=60 --> 32 | Trial completion date: Jan 2017 --> Jan 2018 | Trial primary completion date: Jan 2017 --> Mar 2016 N=50 --> 0 | Not yet recruiting --> Withdrawn